ARCHIVES

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

This article is from The Cancer Letter archive.

Vol. 31 No. 13 | April 1, 2005

Download PDF Visit The Full Archive

Related Articles

Farber Grant Probe Misses Real Story

July 8, 1977

In Brief: NCI Providing Information On Levamisole To Patients; Macdonald Jins Temple, Salick

July 21, 1989

In Brief: Treatment Reorganization Will Give Rauscher “Lumps,” He Says; Coordinating Group Favored

August 16, 1974

“Honor Roll” Of Top Investigators Who Won’t Be Funded Because Of Cuts

March 8, 1985

AC To Refuse Government Help In Future Projects

November 24, 1978

In Brief: Reviewed CCOP Applications Won’t Be Funded; Potter Recruiting For New Medical Oncology Chief

September 30, 1983